INGREZZA $0 Co-pay Program (Neurocrine Access Support)
Neurocrine Biosciences · Ingrezza
Patient pays: as little as $0 per month
commercial insurance
Patient assistance
Tell us your insurance and household details. We’ll show you every Ingrezza assistance program you may qualify for - the real manufacturer and foundation programs, not a discount card - with sources and a direct link to apply. About a minute, no login.
Ingrezza help that still works on Medicare or Medicaid - the programs copay cards leave out.
Ingrezza (valbenazine) is a vmat2 inhibitor (oral) made by Neurocrine Biosciences. It is commonly prescribed for: Tardive dyskinesia, Chorea associated with Huntington's disease. Without financial assistance, Ingrezza typically costs around $8,500 per month.
Tell us five things. We’ll do the rest.
Reference
This is the full list before we filter by your situation. Use the calculator above to see only the ones you may qualify for.
Neurocrine Biosciences · Ingrezza
Patient pays: as little as $0 per month
commercial insurance
Neurocrine Biosciences · Ingrezza
uninsured · underinsured
Common questions